RE:RE:RE:RE:RE:RE:RE:RE:Diabetic Foot Ulcers - plasminogenIt would make sense that all IV related apps of Pg would be phase 4 studies, such as acute Pg deficiency and severe burns. But in the case of wound healing, where the formulation is different as well as the method of application, I wonder what will be the clinical trial process. Hopefully, Phase 1 safety studies can be avoided since we are dealing with micro grams in wound healing applications BUT I think placebo controlled Phase 2/3 studies may be required in these apps. I look forward to next week's AGM to see what clarity can be brought to this issue and the many others facing the company.